UNSPSC 51386000: Nonsteroidal anti inflammatorys, synthesized

This classification denotes Nonsteroidal anti inflammatorys composed of multiple constituents, with no dominant constituent.

UNSPSC 51386000 Nonsteroidal anti-inflammatorys, synthesized (Class) covers the procurement of generic multi-source pharmaceuticals and over-the-counter products by state and local health agencies, though recent solicitations show broader demand for emergency response medications and direct-to-manufacturer prescription programs alongside traditional pharmaceutical supply. State health departments, county health systems, and cooperative purchasing alliances drive procurement under this code. Seminole County, Florida procures naloxone and drug deactivation systems for community health support; the Texas Health and Human Services Commission is exploring direct-to-manufacturer prescription channels to bypass traditional pharmacy benefit managers; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administers multi-state contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon. Work solicited ranges from emergency medical countermeasures (naloxone) to routine generic pharmaceutical supply through authorized wholesalers.

Recent activity spans Florida, Texas, and Minnesota. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, and a two-year initial term with one-year renewal option. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. MMCAP issued RFP S1070000015802 on January 20, 2026, closing March 26, 2026, to establish multi-award generic pharmaceutical contracts effective July 1, 2026, with pricing weighted at 75 percent, requiring vendors to maintain relationships with three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), achieve cGMP and DSCSA compliance, and carry commercial general liability insurance of $5,000,000 per occurrence. MMCAP contracts carry a 3 percent administrative fee and performance penalties of $200 to $1,500 per violation.